Liao Chunxiao, Gao Wenjing, Cao Weihua, Lv Jun, Yu Canqing, Wang Shengfeng, Pang Zengchang, Cong Liming, Wang Hua, Wu Xianping, Li Liming
Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, 100191, People's Republic of China.
Qingdao Center for Diseases Control and Prevention, Qingdao, 266033, People's Republic of China.
Diabetes Metab Syndr Obes. 2021 Mar 15;14:1141-1151. doi: 10.2147/DMSO.S298499. eCollection 2021.
Obesity is a heterogeneous condition in terms of metabolic status. Different obesity phenotypes have various health risks. The aim of this work was to define different subtypes of obesity and investigate their relationship with inflammatory-cardiometabolic abnormalities among Chinese adult twins.
The analyses used data from 1113 adult twins in 4 provinces (Shandong, Zhejiang, Jiangsu and Sichuan) from Chinese National Twin Registry (CNTR) which collected detailed information. We defined those with 0 or 1 metabolic syndrome (MetS) components excluding waist circumference as metabolically healthy, and those with waist circumference ≥90 cm (for men) and ≥85 cm (for women) as obese. The two-category obesity status and metabolic states are combined to generate four metabolic/obesity phenotypes. High sensitivity C reactive protein (hsCRP) was measured to assess underlying inflammation and homeostasis model assessment of insulin resistance (HOMA-IR) was calculated as surrogate measure of insulin resistance. Mixed-effect linear regression models and fixed-effect linear regression models were used to analyse the correlation between HOMA-IR, hsCRP and different metabolic/obesity phenotypes.
In cross-sectional analyses of 1113 individuals (mean [SD] age, 46.6 [12.9] years; 463 obese [41.6%]), 20.3% obese twins were metabolic healthy and 64.2% non-obese twins were metabolic unhealthy. Serum HOMA-IR level was higher in metabolically unhealthy non-obesity (MUNO) (β=0.42, 95% CI: 0.21-0.64), metabolically healthy obesity (MHO) (β=0.68, 95% CI: 0.36-1.00) and metabolically unhealthy obesity (MUO) (β=0.69, 95% CI: 0.46-0.91) twins, compared with their metabolically healthy non-obesity (MHNO) counterparts. HsCRP was similar between MHO and MUO, which differed significantly to metabolic healthy non-obesity (MHNO).
MHO and MUNO phenotypes were common in Chinese twin population. Both phenotypes were associated with elevated IR and hsCRP which may not be benign and need to be concerned.
肥胖在代谢状态方面是一种异质性疾病。不同的肥胖表型具有不同的健康风险。本研究的目的是定义肥胖的不同亚型,并在中国成年双胞胎中研究它们与炎症性心脏代谢异常之间的关系。
分析使用了来自中国国家双胞胎登记处(CNTR)的4个省份(山东、浙江、江苏和四川)的1113名成年双胞胎的数据,该登记处收集了详细信息。我们将那些没有或仅有1项代谢综合征(MetS)组分(不包括腰围)的人定义为代谢健康,将腰围≥90厘米(男性)和≥85厘米(女性)的人定义为肥胖。将两类肥胖状态和代谢状态相结合,产生四种代谢/肥胖表型。测量高敏C反应蛋白(hsCRP)以评估潜在炎症,并计算胰岛素抵抗的稳态模型评估(HOMA-IR)作为胰岛素抵抗的替代指标。使用混合效应线性回归模型和固定效应线性回归模型分析HOMA-IR、hsCRP与不同代谢/肥胖表型之间的相关性。
在对1113名个体(平均[标准差]年龄,46.6[12.9]岁;463名肥胖者[41.6%])的横断面分析中,20.3%的肥胖双胞胎代谢健康,64.2%的非肥胖双胞胎代谢不健康。与代谢健康的非肥胖(MHNO)双胞胎相比,代谢不健康的非肥胖(MUNO)(β=0.42,95%置信区间:0.21-0.64)、代谢健康的肥胖(MHO)(β=0.68,95%置信区间:0.36-1.00)和代谢不健康的肥胖(MUO)(β=0.69,95%置信区间:0.46-0.91)双胞胎的血清HOMA-IR水平更高。MHO和MUO之间的hsCRP相似,与代谢健康的非肥胖(MHNO)有显著差异。
MHO和MUNO表型在中国双胞胎人群中很常见。这两种表型均与IR和hsCRP升高有关,可能并非良性,需要关注。